However, the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) 2021 clinical practice guidelines on the management of Clostridioides difficile infection in adults recommend that fidaxomicin (when available) be used over vancomycin for C difficile infection.